Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Fabíola Cardillo"'
Autor:
Amanda C. O. Silva, Maiara Bonfim, Jonathan L. M. Fontes, Washington L. C. dos-Santos, José Mengel, Fabíola Cardillo
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Chagas disease is accompanied by a multisystem inflammatory disorder that follows Trypanosoma cruzi infection. Alpha-tocopherol has been described as an antioxidant and a potential adjuvant to enhance immune responses to vaccines. Therefore, we have
Externí odkaz:
https://doaj.org/article/3a1d629733484f9ca832f6f61fd2a607
Autor:
Fabíola Cardillo, Maiara Bonfim, Periela da Silva Vasconcelos Sousa, José Mengel, Luiz Roberto Ribeiro Castello-Branco, Rosa Teixeira Pinho
Publikováno v:
Vaccines, Vol 9, Iss 5, p 439 (2021)
Bacillus Calmette–Guérin (BCG), an attenuated vaccine from Mycobacterium bovis, was initially developed as an agent for vaccination against tuberculosis. BCG proved to be the first successful immunotherapy against established human bladder cancer
Externí odkaz:
https://doaj.org/article/fbf66341f2cf4add9eded9875abf0963
Publikováno v:
Frontiers in Immunology, Vol 7 (2016)
Biomarkers or biosignature profiles have become accessible over time in population-based studies for Chagas disease. Thus, the identification of consistent and reliable indicators of the diagnosis and prognosis of patients with heart failure might fa
Externí odkaz:
https://doaj.org/article/74f22e8e80e04fcc909dc74060b7dfdb
Publikováno v:
Immunology letters. 249
The Bacille Calmette-Guérin (BCG) is a potent immunomodulator. It was initially used by oral administration, but it is mostly used subcutaneously nowadays. This study shows that oral BCG vaccination modifies the immune response to a second non-relat
Autor:
Amanda C O, Silva, Maiara, Bonfim, Jonathan L M, Fontes, Washington L C, Dos-Santos, José, Mengel, Fabíola, Cardillo
Publikováno v:
Frontiers in immunology. 13
Chagas disease is accompanied by a multisystem inflammatory disorder that follows
Autor:
Periela da Silva Vasconcelos Sousa, R.T. Pinho, Fabíola Cardillo, Luiz Roberto Ribeiro Castello-Branco, Maiara Bonfim, José Mengel
Publikováno v:
Vaccines
Vaccines, Vol 9, Iss 439, p 439 (2021)
Vaccines, Vol 9, Iss 439, p 439 (2021)
Bacillus Calmette–Guérin (BCG), an attenuated vaccine from Mycobacterium bovis, was initially developed as an agent for vaccination against tuberculosis. BCG proved to be the first successful immunotherapy against established human bladder cancer
Publikováno v:
European Journal of Microbiology and Immunology. 4:128-137
The role of CD25+ regulatory T cells during the course of Trypanosoma cruzi infection has been previously analyzed, and the bulk of results have shown a limited role for this T cell subpopulation. In this study, we have used an IgM, nondepleting mono
Publikováno v:
Journal of Immunology and Serum Biology. 3:120-121
In this article, we discuss an alternative explanation for the fact that the production and plasma levels of IL-17 are diminished in patients chronically infected with Trypanosoma cruzi, suffering from congestive heart failure. This alternate hypothe
Autor:
Luciana Souza, de Aragão-França, Luciana S, Aragão-França, Viviane Costa Junqueira, Rocha, Viviane C J, Rocha, Andre, Cronemberger-Andrade, Fábio Henrique Brasil, da Costa, F H B, Costa, Juliana Fraga, Vasconcelos, José Fernandes, Vasconcelos, Daniel Abensur, Athanazio, Daniela Nascimento, Silva, Emanuelle Souza, Santos, E S, Santos, Cássio Santana, Meira, Cintia Figueiredo, Araujo, C F, Araújo, Jéssica Vieira, Cerqueira, Fabíola, Cardillo, Neuza Maria, Alcântara-Neves, Milena Botelho Pereira, Soares, Lain Carlos, Pontes de Carvalho, Lain C, Pontes-de-Carvalho
Publikováno v:
Allergy, Asthma & Immunology Research
Purpose The use of tolerogenic dendritic cells (TolDCs) to control exacerbated immune responses may be a prophylactic and therapeutic option for application in autoimmune and allergic conditions. The objective of this work was to evaluate the effects
Autor:
Luciana Souza de Aragão-França, Viviane Costa Junqueira Rocha, Andre Cronemberger-Andrade, Fábio Henrique Brasil da Costa, Juliana Fraga Vasconcelos, Daniel Abensur Athanazio, Daniela Nascimento Silva, Emanuelle Souza Santos, Cássio Santana Meira, Cintia Figueiredo Araujo, Jéssica Vieira Cerqueira, Fabíola Cardillo, Neuza Maria Alcântara-Neves, Milena Botelho Pereira Soares, Lain Carlos Pontes de Carvalho
Publikováno v:
Allergy, Asthma & Immunology Research
Purpose The use of tolerogenic dendritic cells (TolDCs) to control exacerbated immune responses may be a prophylactic and therapeutic option for application in autoimmune and allergic conditions. The objective of this work was to evaluate the effects